Instrument Inactif

Autres langues Alpha MOS

Actions

ALNEO

FR0013421286

Equipement et technologie médicale avancés

Autres langues

31/10/24	Alpha MOS S.A. Reports Earnings Results for the Half Year Ended June 30, 2024
18/10/24	Jolt Capital Targeted Opportunities Fund, Ambrosia Investments Limited and Jolt Capital SAS proposed public withdrawal offer to acquire an remaining 10.92% stake in Alpha MOS S.A. for ?1.4 million.
25/04/24	Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
25/04/24	Alpha Mos : FY 2023 RESULTS
05/04/24	Alpha Mos : BOYDSense completes a EUR 7m capital increase to further develop its non-invasive glucose monitoring device
07/03/24	Alpha MOS S.A. announced that it expects to receive ?6.29236 million in funding
30/10/23	Alpha MOS S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
30/10/23	Alpha Mos : INTERIM RESULTS AT 30 JUNE 2023
31/07/23	EU Clears Marketing Authorization for Marinus Pharmaceuticals' Ztalmy
01/06/23	Alpha MOS : Conclusion of the 2nd BOYDSense clinical study
01/06/23	Alpha Mos : Conclusion of the 2nd BOYDSense clinical study
11/05/23	Alpha Mos : Mengniu, a Chinese leader of dairy products validates Alpha MOS electronic noses performance for milk control
28/04/23	Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
07/02/23	Alpha MOS : BOYDSense (an Alpha MOS subsidiary), selected among the 12 most innovative French Medtech by the National Union of the Medical Technology Industry (SNITEM)
12/12/22	Alpha MOS : BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury
09/12/22	Alpha MOS S.A. announced that it has received €3 million in funding from NextStage AM
28/10/22	Alpha MOS S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
30/08/22	Alpha MOS : Development acceleration booster for BOYDSense’s breath analyser platform for people living with Diabetes thanks to the support of the European Innovation Council (EIC)
28/04/22	Alpha MOS SA Reports Earnings Results for the Full Year Ended December 31, 2021
03/02/22	Alpha MOS : Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS
28/01/22	Alpha MOS SA(ENXTPA:ALNEO) dropped from CAC AllShares Index
18/01/22	Alpha MOS : announces the appointment of three Senior Advisors to its Executive Board
16/12/21	Alpha MOS : announces that its MedTech subsidiary BOYDSense has been selected by the European Innovation Council (EIC) Accelerator of the Horizon Europe funding program
25/11/21	Global markets live: Tencent, Vivo Energy, AT&T, Verizon, Petrobras...
17/11/21	Global markets live: Tesla, Experian, Roche, Activision, Amazon...